SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-06-023715
Filing Date
2006-02-08
Accepted
2006-02-08 15:32:58
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G dsc13g.htm SC 13G 44531
  Complete submission text file 0001193125-06-023715.txt   46471
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filed by) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13G
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVE SUITE 350 TAMPA FL 33606 8138642562
ACCENTIA BIOPHARMACEUTICALS INC (Subject) CIK: 0001310094 (see all company filings)

IRS No.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-81399 | Film No.: 06588963
SIC: 2834 Pharmaceutical Preparations